Updates

Cadila Healthcare Ltd has informed BSE that Companys US based 100% subsidiary company Zydus Pharmaceuticals (USA) Inc. (Zydus) will begin informing on July 12, 2016 its customers that Zydus will start selling an authorized generic of Asacol HD (mesalamine delayed - release tablets 800 mg) in the United States commencing on August 01, 2016.

Source : BSE - >www.bseindia.com

Published on July 14, 2016
TOPICS

Related

This article is closed for comments.
Please Email the Editor